Geisinger limits visitors, sets restrictions to help protect against COVID spread

DANVILLE, Pa. – As COVID-19 cases continue to increase systemwide, we are limiting visitors for inpatient settings. Effective, Monday, Dec. 20, one visitor is permitted per hospitalized adult patient. Other family members, friends and general visitors will not be permitted at this time.

In our system, one in four inpatients has COVID and we are reaching or exceeding capacity in some hospitals. These guidelines protect the health and safety of our patients and staff. Having fewer visitors allows our staff to focus on treating our patients.

The visitor must be designated and wear a wristband the entire time the patient is hospitalized. Visiting hours are between 9 a.m. and 6 p.m. All patients and visitors must wear a mask when on Geisinger property, regardless of vaccination status. Visitors who do not comply with Geisinger’s policies, such as masking, will lose their visiting rights.

For general questions and information about COVID-19, visit geisinger.org/coronavirus.

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country.  Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.